版權說明：本文檔由用戶提供并上傳，收益歸屬內容提供方，若內容存在侵權，請進行舉報或認領
文檔簡介
StrategicChangesintheGlobalPharmaceuticalMarketStrategicChangesintheGlob行業報告,全球制藥業發展戰略課件
GenericMedicinesarepartoftheSolutionforAgeingPopulations
China/Indiawith37%population,14%ofwealthandmostoftheGDPgrowthChina/Indiawith37%populatioStructuralChange-BigPharmaStructuralChange-
In2010,FDAapprovedOnly21NewDrugSource:Fiercebiotech22Jan2011
USADept.ofJFinesonBigPharmaSource:ChemistryWorldJan2011
USABatchRecallsSource:DeutchenBank29March2011
Approvals&ReimbursementsSource:PharmatimesUKJuly-August2010
BigPharmaLosingtoLocalPlayersSourceGSKPresentation
EmergingWorldShareofPharmaSourceEIU,OECD,WHO,IMS,RolandBerger
Top8CosinEmergingMarkets2008
IncreasingPaceofEmergingMarketsAcquisitionsEmergingMarketInvestorDaysMarch16,2010
December10,2009
July2,2009
LargePharmaEnteringGenerics(Egypt,Pakistan,NearEast)(MENA,LatAm,Asia-Pac)(Algeria)Withtheslow-downofWesternmarkets,PharmaarerapidlyrepositioningtofocusonemergingmarketsforgrowthIncreasingPaceofEmergingMa
SalesForceJobCutsinPresssince2009
StructuralChangeGenericCompaniesStructuralChange
Asiavs.theWesternGenericCompaniesSource:Factset,Religare
PricingPressuresSource:Watson
EuropeanGenericPricesSourceRanbaxy
EuropeanGenericPricesSourceRanbaxy
USA-ANDAGrowingApprovalTimes
SourceFDAChiefMHamburg,GpHAConferenceFebruary2010200516.3monthsaverage200926.7monthsaverageAround2000ANDAsawaitingapprovalFDAexplainedasaresultofstaffshortagesRegulatoryfilingfeesneededUSA-ANDAGrowingApprovalTi
SeasonofWarningLetters/ImportAlertsSource:DeutcheBankJuly2011
USA-LitigationSuccessRatesSourceRBCCapitalMarketsJanuary152010PatentChallengesonrise-65FTFsin2009Successrateat48%-or76%includingdeals3courtshold69%with36%successe.g.NJ4courtsneverruledagainstgenericse.g.NYAtrisklaunchesontherise–6in2009Tevahas12ofthe28atrisklaunches–2002/9Settlementsontherise–54in2009TevaaccountsforathirdofallsettlementsAuthorizedgenericsontherise–25in2009WatsonrepresentsafifthofallAGsUSA-LitigationSuccessRates
GenericProfitMarginProfileindescendingordersource:DeutscheBankJuly2010
Top25GlobalGenericCompaniesSource:GenericsBulletin10June2011
Next24GlobalGenericCompaniesSource:GenericsBulletin10June2011
PatentExpiriesSource:Sandoz
In2016,AmongTop10,8willbeBiologic/Resp
Source:SandozEGAConference2011
StructuralChangesIndianPharmaCompaniesStructuralChangesWHOPreQualifiedProductsWHOPreQualifiedProducts
IndianGenericFDAANDAApprovals
NicheTechnologySource:MAPE
India–ShareofCRAMSMarketIndia–ShareofCRAMSMarket
LotsofOpportunityforCROsinIndiaSource:16Feb2011
MacroStructuralChangesMacroStructuralChanges
Pfizer&Hisun
PharmaWholesalersetsupChinaJV
UKCoop–theworld’slargestconsumercooperativeGBP￡10bUKcompanyrunningfoodstores,banks,insurance,funeralhomes,travelagents,farmsandpharmacies3rdrankpharmacychaininUKwith800storesOwnsUKpharmaceuticalwholesalerSantsOpusMarketingJVwithDayLewisPharmacyChainoffers113productsunderProspectbrandTianjinTaslySantsManufacturingJVopened2010,“productionunderway”Jun2011WithInvestmentGBP￡20m,200staffPharmaWholesalersetsupChin
ChinaPharmaIndustryCapexPlansSource:Stravencom
IndiaPharmaIndustryCapexPlansSource:MAPE
FDADMFsfromIndia
FDADMFsfromChina
ChineseANDAs
EndangeredElements
Source:ChemistryWorld2011
ANewWorldOrderisComing
行業報告,全球制藥業發展戰略課件演講完畢，謝謝觀看！演講完畢，謝謝觀看！
StrategicChangesintheGlobalPharmaceuticalMarketStrategicChangesintheGlob行業報告,全球制藥業發展戰略課件
GenericMedicinesarepartoftheSolutionforAgeingPopulations
China/Indiawith37%population,14%ofwealthandmostoftheGDPgrowthChina/Indiawith37%populatioStructuralChange-BigPharmaStructuralChange-
In2010,FDAapprovedOnly21NewDrugSource:Fiercebiotech22Jan2011
USADept.ofJFinesonBigPharmaSource:ChemistryWorldJan2011
USABatchRecallsSource:DeutchenBank29March2011
Approvals&ReimbursementsSource:PharmatimesUKJuly-August2010
BigPharmaLosingtoLocalPlayersSourceGSKPresentation
EmergingWorldShareofPharmaSourceEIU,OECD,WHO,IMS,RolandBerger
Top8CosinEmergingMarkets2008
IncreasingPaceofEmergingMarketsAcquisitionsEmergingMarketInvestorDaysMarch16,2010
December10,2009
July2,2009
LargePharmaEnteringGenerics(Egypt,Pakistan,NearEast)(MENA,LatAm,Asia-Pac)(Algeria)Withtheslow-downofWesternmarkets,PharmaarerapidlyrepositioningtofocusonemergingmarketsforgrowthIncreasingPaceofEmergingMa
SalesForceJobCutsinPresssince2009
StructuralChangeGenericCompaniesStructuralChange
Asiavs.theWesternGenericCompaniesSource:Factset,Religare
PricingPressuresSource:Watson
EuropeanGenericPricesSourceRanbaxy
EuropeanGenericPricesSourceRanbaxy
USA-ANDAGrowingApprovalTimes
SourceFDAChiefMHamburg,GpHAConferenceFebruary2010200516.3monthsaverage200926.7monthsaverageAround2000ANDAsawaitingapprovalFDAexplainedasaresultofstaffshortagesRegulatoryfilingfeesneededUSA-ANDAGrowingApprovalTi
SeasonofWarningLetters/ImportAlertsSource:DeutcheBankJuly2011
USA-LitigationSuccessRatesSourceRBCCapitalMarketsJanuary152010PatentChallengesonrise-65FTFsin2009Successrateat48%-or76%includingdeals3courtshold69%with36%successe.g.NJ4courtsneverruledagainstgenericse.g.NYAtrisklaunchesontherise–6in2009Tevahas12ofthe28atrisklaunches–2002/9Settlementsontherise–54in2009TevaaccountsforathirdofallsettlementsAuthorizedgenericsontherise–25in2009WatsonrepresentsafifthofallAGsUSA-LitigationSuccessRates
GenericProfitMarginProfileindescendingordersource:DeutscheBankJuly2010
Top25GlobalGenericCompaniesSource:GenericsBulletin10June2011
Next24GlobalGenericCompaniesSource:GenericsBulletin10June2011
PatentExpiriesSource:Sandoz
In2016,AmongTop10,8willbeBiologic/Resp
Source:SandozEGAConference2011
StructuralChangesIndianPharmaCompaniesStructuralChangesWHOPreQualifiedProductsWHOPreQualifiedProducts
IndianGenericFDAANDAApprovals
NicheTechnologySource:MAPE
India–ShareofCRAMSMarketIndia–ShareofCRAMSMarket
LotsofOpportunityforCROsinIndiaSource:16Feb2011
MacroStructuralChangesMacroStructuralChanges
Pfizer&Hisun
PharmaWholesalersetsupChinaJV
UKCoop–theworld’slargestconsumercooperative
溫馨提示
- 1. 本站所有資源如無特殊說明，都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等，如果需要附件，請聯系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙，網頁內容里面會有圖紙預覽，若沒有圖紙預覽就沒有圖紙。
- 4. 未經權益所有人同意不得將文件中的內容挪作商業或盈利用途。
- 5. 人人文庫網僅提供信息存儲空間，僅對用戶上傳內容的表現方式做保護處理，對用戶上傳分享的文檔內容本身不做任何修改或編輯，并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容，請與我們聯系，我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 代發企業活動方案
- 代理門檻活動方案
- 代賬公司漲價活動方案
- 以大帶小閱讀活動方案
- 仿課教研活動方案
- DB61T-牛羊無布魯氏菌病區建設 第3部分 檢查消毒站（點）編制說明
- 企業三聯系活動方案
- 企業人才進校園活動方案
- 企業八一活動方案
- 企業冬奧宣傳活動方案
- 靜密封管理制度
- 高中主題班會 你好高二！課件-高二上學期第一次主題班會
- 乙狀結腸破裂護理業務查房
- 醫院職能科室科務會制度
- 《中國腦卒中防治報告(2023)》
- 成人禮活動流程
- 房地產銷售代理合同示范文本
- 外貿企業國際貿易合規操作手冊
- 第十七章勾股定理數學活動 教學設計2024-2025學年人教版數學八年級下冊
- 2024年湖南省普通高中學業水平合格性考試歷史試題（原卷版+解析版）
- 【中考一模】2025年中考數學試題及答案（成都專用）
評論
0/150
提交評論